CD19 is a protein commonly found on B cells, and has been successfully targeted in B-cell malignancies such as acute lymphoblastic leukemia (ALL) and non-Hodgkin lymphoma (NHL). This evidence concerns the gene CD19 and acute lymphoblastic leukemia.